Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Group Calls For Public-Private Partnership To Develop Value-Driven Devices

This article was originally published in The Gray Sheet

Executive Summary

The Austen BioInnovation Institute in Akron is seeking the creation of a public-private partnership to develop medical devices based on value-driven engineering principles, and plans to meet with stakeholders to discuss the idea over the coming months.

You may also be interested in...

Regulatory News In Brief

News on a Synthes sentencing, Riata recall and other regulatory developments.

AdvaMed Pushes For Medical Innovation Office In White House

Device industry trade group AdvaMed is urging the Obama administration to create an office of medical innovation policy within the White House.

CDRH's Innovation Pathway: A Quicker Route For Breakthrough Devices?

For a select few devices per year, FDA says it will speed up pre-market development times by intensifying staff efforts, with a particular focus on very early-stage, frequent interactions with product sponsors.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts